ADCT
ADC Therapeutics SA
1.30$
-1.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 9,585.0% | 9,585.0% | 11,297.1% | 11,297.1% | 1,990.3% | 1,109.1% | – | – | – | – | 62.0% | 50.0% | 1.1% | 3.2% | 3.8% | 4.5% | 1.1% | 13.1% | 1.7% | 0.7% | -0.1% | 5.9% | 2.5% | 745.4% | 13.9% | 7.0% | 4.6% | 8.1% | 8.9% | 4.4% | 7.3% | 7.4% | 18.0% | 12.2% | 11.3% | |
| -9,485.0% | -9,485.0% | -11,197.1% | -11,197.1% | -1,890.3% | -1,009.1% | – | – | – | – | -62.0% | 50.0% | -1.1% | 96.8% | 96.2% | 95.5% | 98.9% | 86.9% | 98.3% | 99.3% | 100.1% | 94.1% | 97.5% | -645.4% | 86.1% | 93.0% | 95.4% | 91.9% | 91.1% | 95.6% | 92.7% | 92.6% | 82.0% | 87.8% | 88.7% | |
| 9,621.3% | 9,621.3% | 11,297.1% | 11,297.1% | 1,990.3% | 1,109.1% | – | – | – | – | 62.0% | 93.5% | 75.5% | 1,051.4% | 279.9% | 249.8% | 105.3% | 280.7% | 54.6% | 69.8% | 202.1% | 162.5% | 196.2% | 180.6% | 142.6% | 139.5% | 176.0% | 160.3% | 125.6% | 159.7% | 163.2% | 78.9% | 99.2% | 90.2% | 104.4% | |
| 619.0% | 619.0% | 951.3% | 951.3% | 281.7% | 208.4% | – | – | – | – | 39.1% | 38.7% | 33.9% | 515.1% | 126.2% | 166.1% | 40.9% | 120.1% | 37.0% | 21.7% | 124.1% | 94.0% | 103.9% | 67.3% | 97.5% | 92.4% | 84.6% | 89.6% | 43.2% | 79.4% | 85.3% | 67.6% | 49.4% | 50.4% | 62.5% | |
| 646.4% | 646.4% | 920.8% | 920.8% | 284.6% | 1,317.5% | – | – | – | – | 101.0% | 150.3% | 136.2% | 1,971.3% | 535.8% | 464.6% | 185.7% | 488.3% | 102.4% | 114.7% | 364.5% | 299.7% | 355.6% | -407.2% | 272.3% | 259.8% | 288.0% | 283.7% | 214.6% | 329.9% | 277.3% | 171.2% | 208.0% | 219.8% | 214.6% | |
| -10,120.0% | -10,120.0% | -12,128.9% | -12,128.9% | -2,172.0% | -1,217.5% | – | – | – | – | -101.0% | -150.3% | -136.2% | -1,874.5% | -439.6% | -369.1% | -86.8% | -401.4% | -4.1% | -15.4% | -264.4% | -205.6% | -258.1% | -238.1% | -186.2% | -166.8% | -192.6% | -191.8% | -123.6% | -234.3% | -184.6% | -78.6% | -126.0% | -132.0% | -125.8% | |
| 11.7% | 11.7% | – | – | 3.1% | 1.8% | – | – | – | – | 3.7% | 3.9% | 3.9% | 68.0% | 32.4% | 56.0% | 19.8% | 50.9% | 14.9% | 14.0% | 54.2% | 53.5% | 89.3% | 45.7% | 69.2% | 72.8% | 71.0% | 70.5% | 53.1% | 69.0% | 81.5% | 56.4% | 61.6% | 70.2% | 66.4% | |
| -9,868.8% | -9,868.8% | -11,881.9% | -11,881.9% | -2,122.2% | -1,185.2% | – | – | – | – | -39.2% | -107.5% | -99.1% | -1,923.6% | -543.1% | -331.3% | -38.3% | -377.8% | -67.2% | -28.9% | -309.9% | -277.0% | -330.5% | -249.3% | -257.3% | -208.6% | -237.6% | -183.6% | -166.9% | -294.0% | -249.4% | -29.5% | -164.6% | -86.1% | -123.5% | |
| 23.7% | 23.7% | 14.8% | 14.8% | 8.5% | 4.8% | – | – | – | – | 0.0% | 0.2% | 0.2% | 6.4% | 1.1% | -129.2% | -2.5% | -5.5% | -0.9% | 5.7% | 2.7% | -23.3% | -0.6% | 257.1% | 0.9% | 1.3% | 0.5% | -1.9% | 0.7% | 6.7% | -1.6% | -1.8% | – | – | – | |
| -9,892.5% | -9,892.5% | -11,896.7% | -11,896.7% | -2,130.7% | -1,190.0% | – | – | – | – | -39.2% | -107.8% | -99.3% | -1,930.0% | -544.2% | -202.1% | -35.8% | -372.3% | -66.3% | -34.6% | -312.6% | -253.7% | -329.9% | -506.4% | -258.2% | -209.9% | -238.1% | -181.7% | -167.6% | -300.7% | -249.4% | -27.8% | -164.6% | -86.1% | -123.0% | |
| -10,084.2% | -10,084.2% | -12,077.7% | -11,979.8% | -2,160.5% | -1,176.5% | – | – | – | – | -34.5% | -102.9% | -94.1% | -1,838.8% | -488.9% | -270.9% | -17.2% | -323.5% | -51.6% | -17.3% | -244.7% | -215.4% | -227.6% | -201.6% | -179.6% | -127.5% | -160.9% | -111.4% | -111.5% | -220.6% | -167.1% | 27.4% | -101.8% | -238.7% | -111.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.